Literature DB >> 24337918

Relation of plasma adiponectin levels and aortic stiffness after acute ST-segment elevation myocardial infarction.

S J Reinstadler1, G Klug, H J Feistritzer, A Mayr, K Bader, J Mair, R Esterhammer, M Schocke, B Metzler.   

Abstract

BACKGROUND: Pulse wave velocity is a measure of aortic stiffness and an independent predictor of cardiovascular morbidity and mortality. Adiponectin is involved in atherosclerosis and inflammation. In the present study we aimed to explore the association between plasma adiponectin concentrations and pulse wave velocity in the acute phase after ST-segment elevation myocardial infarction (STEMI).
METHODS: Forty-six consecutive STEMI patients (mean age 57 ± 11 years) treated with primary percutaneous coronary intervention (PCI) were enrolled in this cross-sectional study. Plasma adiponectin was measured 2 days after index event by enzyme-linked immunosorbent assay. Aortic pulse wave velocity (PWV) was calculated by the transit-time method with the use of a velocity-encoded, phase-contrast cardiac magnetic resonance protocol.
RESULTS: Median plasma adiponectin concentration was 2385 ng/ml (interquartile range 1735-5403). Males had lower plasma adiponectin values than females and current smokers had lower values than non-smokers (all p<0.02). Adiponectin was significantly associated with PWV (r=0.505, p<0.001), age (r=0.437, p=0.002), and total cholesterol (r=0.468, p=0.001). Multiple linear regression analysis revealed adiponectin as a predictor of PWV independently of age, sex, smoking status, total cholesterol, and N-terminal pro-B-type natriuretic peptide (p=0.027).
CONCLUSIONS: Plasma adiponectin concentrations are strongly associated with aortic stiffness in patients after acute STEMI treated with primary PCI. Our data support a possible role for adiponectin as an independent risk marker for increased aortic stiffness in STEMI patients.

Entities:  

Keywords:  Adiponectin; ST-segment elevation myocardial infarction; aortic stiffness; cardiac magnetic resonance; pulse wave velocity

Mesh:

Substances:

Year:  2013        PMID: 24337918      PMCID: PMC3932779          DOI: 10.1177/2048872613516015

Source DB:  PubMed          Journal:  Eur Heart J Acute Cardiovasc Care        ISSN: 2048-8726


  37 in total

1.  Serum adiponectin is a predictor of coronary heart disease: a population-based 10-year follow-up study in elderly men.

Authors:  Jan Frystyk; Christian Berne; Lars Berglund; Karin Jensevik; Allan Flyvbjerg; Björn Zethelius
Journal:  J Clin Endocrinol Metab       Date:  2006-11-21       Impact factor: 5.958

2.  Adiponectin and cardiovascular mortality: evidence for "reverse epidemiology".

Authors:  W Rathmann; C Herder
Journal:  Horm Metab Res       Date:  2007-01       Impact factor: 2.936

Review 3.  Aortic stiffness: current understanding and future directions.

Authors:  João L Cavalcante; João A C Lima; Alban Redheuil; Mouaz H Al-Mallah
Journal:  J Am Coll Cardiol       Date:  2011-04-05       Impact factor: 24.094

4.  Usefulness of adiponectin as a predictor of all cause mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.

Authors:  Søren Lindberg; Sune H Pedersen; Rasmus Møgelvang; Mette Bjerre; Jan Frystyk; Allan Flyvbjerg; Søren Galatius; Jan Skov Jensen
Journal:  Am J Cardiol       Date:  2011-11-19       Impact factor: 2.778

Review 5.  Adiponectin and cardiovascular health: an update.

Authors:  Xiaoyan Hui; Karen S L Lam; Paul M Vanhoutte; Aimin Xu
Journal:  Br J Pharmacol       Date:  2012-02       Impact factor: 8.739

Review 6.  Prognostic significance of cardiac magnetic resonance imaging: Update 2010.

Authors:  Vinzenz Hombach; Nico Merkle; Peter Bernhard; Volker Rasche; Wolfgang Rottbauer
Journal:  Cardiol J       Date:  2010       Impact factor: 2.737

7.  Measuring aortic pulse wave velocity using high-field cardiovascular magnetic resonance: comparison of techniques.

Authors:  El-Sayed H Ibrahim; Kevin R Johnson; Alan B Miller; Jean M Shaffer; Richard D White
Journal:  J Cardiovasc Magn Reson       Date:  2010-05-11       Impact factor: 5.364

8.  In vivo measurement of local aortic pulse-wave velocity in mice with MR microscopy at 17.6 Tesla.

Authors:  Volker Herold; Marco Parczyk; Philipp Mörchel; Christian H Ziener; Gert Klug; Wolfgang R Bauer; Eberhard Rommel; Peter M Jakob
Journal:  Magn Reson Med       Date:  2009-06       Impact factor: 4.668

9.  Validation and reproducibility of aortic pulse wave velocity as assessed with velocity-encoded MRI.

Authors:  Heynric B Grotenhuis; Jos J M Westenberg; Paul Steendijk; Rob J van der Geest; Jaap Ottenkamp; Jeroen J Bax; J Wouter Jukema; Albert de Roos
Journal:  J Magn Reson Imaging       Date:  2009-09       Impact factor: 4.813

10.  Relation of adiponectin and high-sensitivity C-reactive protein to pulse-wave velocity and N-terminal pro-B-type natriuretic peptide in the general population.

Authors:  Shih-Hsien Sung; Shao-Yuan Chuang; Wayne Huey-Herng Sheu; Wen-Jane Lee; Pesus Chou; Chen-Huan Chen
Journal:  Am J Cardiol       Date:  2009-04-01       Impact factor: 2.778

View more
  14 in total

Review 1.  Cardiovascular Adiponectin Resistance: The Critical Role of Adiponectin Receptor Modification.

Authors:  Yajing Wang; Xin L Ma; Wayne Bond Lau
Journal:  Trends Endocrinol Metab       Date:  2017-05-01       Impact factor: 12.015

2.  Prognostic value of left ventricular global function index in patients after ST-segment elevation myocardial infarction.

Authors:  Sebastian J Reinstadler; Gert Klug; Hans-Josef Feistritzer; Markus Kofler; Bastian Pernter; Georg Göbel; Benjamin Henninger; Silvana Müller; Wolfgang-Michael Franz; Bernhard Metzler
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2015-06-07       Impact factor: 6.875

3.  Prognostic significance of transaminases after acute ST-elevation myocardial infarction: insights from a cardiac magnetic resonance study.

Authors:  Sebastian J Reinstadler; Martin Reindl; Hans-Josef Feistritzer; Gert Klug; Agnes Mayr; Markus Kofler; Alexander Minh-Duc Tu; Luc Huybrechts; Johannes Mair; Wolfgang-Michael Franz; Bernhard Metzler
Journal:  Wien Klin Wochenschr       Date:  2015-10-06       Impact factor: 1.704

4.  Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.

Authors:  Chang Seong Kim; Eun Hui Bae; Seong Kwon Ma; Sue K Park; Ju Yeon Lee; Wookyung Chung; Kyubeck Lee; Yeong Hoon Kim; Kook-Hwan Oh; Curie Ahn; Soo Wan Kim
Journal:  Clin Exp Nephrol       Date:  2016-08-11       Impact factor: 2.801

5.  Comparison of an oscillometric method with cardiac magnetic resonance for the analysis of aortic pulse wave velocity.

Authors:  Hans-Josef Feistritzer; Sebastian J Reinstadler; Gert Klug; Christian Kremser; Benjamin Seidner; Regina Esterhammer; Michael F Schocke; Wolfgang-Michael Franz; Bernhard Metzler
Journal:  PLoS One       Date:  2015-01-22       Impact factor: 3.240

6.  The effect of adiponectin on osteonectin gene expression by oxidized low density lipoprotein-treated vascular smooth muscle cells.

Authors:  Sara Niknam; Keihan Ghatreh-Samani; Effat Farrokhi
Journal:  Int J Mol Cell Med       Date:  2015

Review 7.  Copeptin testing in acute myocardial infarction: ready for routine use?

Authors:  Sebastian Johannes Reinstadler; Gert Klug; Hans-Josef Feistritzer; Bernhard Metzler; Johannes Mair
Journal:  Dis Markers       Date:  2015-04-16       Impact factor: 3.434

8.  Biomarkers of hemodynamic stress and aortic stiffness after STEMI: a cross-sectional analysis.

Authors:  Sebastian Johannes Reinstadler; Hans-Josef Feistritzer; Gert Klug; Agnes Mayr; Luc Huybrechts; Angelika Hammerer-Lercher; Johannes Mair; Wolfgang-Michael Franz; Bernhard Metzler
Journal:  Dis Markers       Date:  2015-04-16       Impact factor: 3.434

9.  Adiponectin is not associated with blood pressure in normotensives and untreated hypertensives with normal kidney function.

Authors:  Vanja Ivković; Mislav Jelaković; Mario Laganović; Ivan Pećin; Ana Vrdoljak; Sandra Karanović; Mirjana Fuček; Tamara Božina; Jelena Kos; Tajana Željković Vrkić; Vedran Premužić; Marijana Živko; Bojan Jelaković
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

10.  Pioglitazone improves the cardio-ankle vascular index in patients with type 2 diabetes mellitus treated with metformin.

Authors:  Masahiro Ohira; Takashi Yamaguchi; Atsuhito Saiki; Noriko Ban; Hidetoshi Kawana; Ayako Nagumo; Takeyoshi Murano; Kohji Shirai; Ichiro Tatsuno
Journal:  Diabetes Metab Syndr Obes       Date:  2014-07-17       Impact factor: 3.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.